SCHEMBL7701622

SCHEMBL7701622

CS(=O)(=O)NCC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1Oc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.44
NPSR1 Q6W5P4 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
RECQL P46063 1/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 2/20 0.42
GAA P10253 1/20 0.42
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42
ATM Q13315 1/20 0.42
ICMT O60725 3/20 0.42
RAB9A P51151 1/20 0.42
BCL2L1 Q07817 1/20 0.41
KCNQ3 O43525 2/20 0.40
KCNQ2 O43526 2/20 0.40
KCNQ5 Q9NR82 1/20 0.40
CA12 O43570 2/20 0.40
CA9 Q16790 2/20 0.40
MAPK8 P45983 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7701336 0.88 CASP1 (0.49) L3MBTL1NPSR1MEN1KMT2ARECQL
SCHEMBL7421842 0.86 L3MBTL1 (0.46) L3MBTL1NPSR1MEN1KMT2ARECQL
SCHEMBL7694696 0.85 KDM4E (0.47) L3MBTL1NPSR1MEN1KMT2ARECQL
SCHEMBL7694147 0.83 ACE (0.46) L3MBTL1NPSR1MEN1KMT2ARECQL
SCHEMBL7695358 0.82 CHRNB2 (0.47) L3MBTL1CA2ITGB1ITGA4ITGB7
SCHEMBL7691777 0.78 CAPN1 (0.58) L3MBTL1KMT2ACA2ITGB1ITGA4
SCHEMBL7675029 0.76 L3MBTL1 (0.44) L3MBTL1NPSR1MEN1KMT2AKDM4E
SCHEMBL7694857 0.76 CA2 (0.43) CA1CA2
SCHEMBL7688546 0.75 KCNA5 (0.46) BCL2L1
SCHEMBL7690013 0.75 CAPN1 (0.68) KMT2ACA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed